This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time.
Will there or won’t there be a federal moratorium on state-level regulation of AI?That’s only one question healthcare stakeholders are asking as 2025’s time begins running out.
Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.
Hospitals could be turning away high-risk heart patients to help their TAVR programs receive a higher ranking, according to new research published in JACC: Cardiovascular Interventions.
Patients who need renal replacement therapy after TAVR are much less likely to survive. Researchers hope their new risk score can help care teams prepare ahead of time for this rare, but potentially fatal complication.
Critics say the model caters to the wealthy while taking primary care physicians out of circulation for everyone else. Not so, respond concierge proponents.
Hospitals short on cash are more likely than their financially flush counterparts to offer patients interest-accruing loans or credit cards to pay for their care.
Cardiologists were asked to develop a care strategy for CAD patients before and after using an FDA-approved AI tool to evaluate CT results. In two out of three cases, the AI influenced cardiologists to modify their original plan.
The past four years have witnessed major advancements in medical science’s drive to unravel the complexities of the human immune system. We have the COVID-19 pandemic to thank for much of the progress.
The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more space for operators to guide and maneuver the catheter during procedures.